RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R2032633 | KNK437 | KNK437 is a HSP inhibitor, and inhibits the induction of HSP105, HSP70, and HSP4 |
| R2032634 | Cligosiban(PF-3274167) | Cligosiban (PF-3274167), a high oral bioavailability and good brain-penetrant no |
| R2032635 | SANT-1 | SANT-1 is a potent Smo antagonist, inhibits Hedgehog signaling, with IC50s of 20 |
| R2032636 | SB239063 | SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits |
| R2032637 | AEE788(NVP-AEE788) | AEE788 is an inhibitor of the EGFR and ErbB2 with IC50 values of 2 and 6 nM, res |
| R2032638 | DDR1-IN-1 | DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with |
| R2032639 | Decernotinib(VX-509) | Decernotinib is a potent, orally active JAK3 inhibitor, with Kis of 2.5, 11, 13 |
| R2032640 | EGF816;Nazartinib | Nazartinib (EGF816) is a novel, covalent mutant-selective EGFR inhibitor, with K |
| R2032641 | GSK5959 | GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor w |
| R2032642 | MK8245 | MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, wit |
| R2032643 | NS6180 | NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prev |
| R2032644 | OF-1 | OF-1 is a selective BRPF1B and BRPF2 bromodomain inhibitor with Kd values of 100 |
| R2032645 | RQ-00203078 | RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist |
| R2032646 | T-5224 | T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with a |
| R2032647 | TCS5861528 | Chembridge-5861528 is a TRPA1 channel blocker that antagonizes AITC- and 4-HNE-e |
| R2032648 | UNC0224 | UNC0224 is a potent and selective G9a inhibitor with IC50 of 15 nM in the G9a Th |
| R2032649 | VER155008 | VER-155008 is an inhibitor of Hsp70, with IC50s of 0.5 μM, 2.6 μM, and 2.6 μM fo |
| R2032650 | Vorapaxar;SCH530348 | Vorapaxar (SCH 530348), an antiplatelet agent, is a selective, orally active, an |
| R2032651 | Voreloxin(SNS-595;AG 7352) | Voreloxin (SNS-595; Vosaroxin; AG 7352) is a first-in-class topoisomerase II inh |
| R2032652 | ZM447439 | ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora |
| R2032653 | CCT244747 | CCT244747 is a potent, orally bioavailable and highly selective CHK1 inhibitor, |
| R2032654 | AVN944 | AVN-944(VX-944) is a selective, noncompetitive inhibitor of the enzyme directed |
| R2032655 | AZD2461 | AZD-2461 is a potent PARP inhibitor, with IC50s of 5 nM, 2 nM and 200 nM for PAR |
| R2032656 | AZD-5597 | AZD-5597 is potent CDK inhibitor with in vitro anti-proliferative effects agains |
| R2032657 | BET bromodomain inhibitor | BET bromodomain inhibitor is a potent BET inhibitor extracted from patent WO/201 |
